Levy Morgan S, Samarakoon Thilani, Smith Caleigh, Goo Irene, Duthely Lunthita M, Van Zuilen Maria, Huang Marilyn, Pillai Asha B
Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.
Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, United States.
Front Oncol. 2024 Oct 15;14:1450475. doi: 10.3389/fonc.2024.1450475. eCollection 2024.
The objective of this study was to evaluate global longitudinal publication trends in oncology in the Cochrane Database of Systematic Reviews (CDSR) from 2001-2020.
Retrospective bibliometric analysis.
The primary outcome measures were the numbers and percentages of women as first, last, and corresponding author across all CDSR oncology publications. Additional outcomes included authorship differences between countries and percentages of women authors over time compared using the Cochran-Armitage trend test.
In total, 548 articles were analyzed. Women were first authors in 52.26% (n=277) and corresponding authors in 50.75% (n=272), respectively. Women represented only 39.4% (n=210) of last authors, significantly less frequent than male counterparts (p < 0.001). The percentage of women last and corresponding authors has increased significantly in the past 20 years (p < 0.05). Countries such as the Netherlands and Australia consistently showed equitable representation in first, corresponding, and last authorship, while other countries such as Italy and China had uniformly low rates of female authorship.
Our results highlight patterns of gender inequity in oncology publication authorship in the CDSR from 2001-2020 at a global level. Notably, women were less likely to serve in the last author position which, independent of assigned corresponding authorship, is generally assumed in academic oncology to designate the leader of a published study. Substantive efforts to correct this disparity are needed to achieve gender parity in publicly perceived leadership in oncology publications.
本研究的目的是评估2001年至2020年Cochrane系统评价数据库（CDSR）中肿瘤学领域全球纵向发表趋势。
回顾性文献计量分析。
主要结局指标是CDSR中所有肿瘤学出版物中女性作为第一作者、最后作者和通讯作者的数量及百分比。其他结局包括国家间的作者身份差异，以及使用 Cochr an-Armitage趋势检验比较不同时间女性作者的百分比。
共分析了548篇文章。女性分别占第一作者的52.26%（n = 277）和通讯作者的50.75%（n = 272）。女性仅占最后作者的39.4%（n = 210），明显低于男性同行（p < 0.001）。在过去20年中，女性最后作者和通讯作者的百分比显著增加（p < 0.05）。荷兰和澳大利亚等国家在第一作者、通讯作者和最后作者身份方面始终表现出公平的代表性，而意大利和中国等其他国家女性作者比例一直较低。
我们的结果突出了2001年至2020年全球范围内CDSR中肿瘤学出版物作者身份方面的性别不平等模式。值得注意的是，女性担任最后作者的可能性较小，在学术肿瘤学中，独立于指定的通讯作者身份，最后作者通常被认为是已发表研究的负责人。需要做出实质性努力来纠正这种差异以在肿瘤学出版物的公众认知领导力方面实现性别平等。
